| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2997 |
| Trial ID | NCT05336409 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CNTY-101 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies |
| Year | 2022 |
| Country | United States |
| Company sponsor | Century Therapeutics, Inc. |
| Other ID(s) | CNTY-101-111-01 |
| Cohort 1 | |||||||||
|
|||||||||